N-Ethylhexedrone
N-Ethylhexedrone (also known as Hexen and NEH) is a stimulant compound of the cathinone class. Cathinones are a sub-category of amphetamines, sharing the core amphetamine structure of a phenyl ring bound to an amino (NH2) group through an ethyl chain and an additional methyl substitution at Rα.
N-Ethylhexedrone was first mentioned in a series of patents by Boehringer Ingelheim in the 1960s which led to the development of the better-known drug methylenedioxypyrovalerone (MDPV). Since the mid-2010s, N-ethylhexedrone has been sold online as a designer drug and is often used for recreational purposes.
Effects[edit]
The effects of N-Ethylhexedrone have been described by users as having a moderate to high stimulant effect, similar to the effects of methamphetamine. It is often associated with a high level of euphoria, increased energy, elevated mood, and increased sociability. However, it can also cause negative effects such as anxiety, paranoia, and increased heart rate.
Legal Status[edit]
The legal status of N-Ethylhexedrone varies by country. In the United States, it is not regulated under the Controlled Substances Act, but it is listed as a Schedule I substance in Florida. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act.
Health Risks[edit]
As with other stimulants, the use of N-Ethylhexedrone can lead to intense cravings and compulsive drug-taking behavior. The drug can also cause a range of health problems, including heart disease, psychosis, and severe neurological damage. It is highly advised to use harm reduction practices if using this substance.
See Also[edit]
